lobbying_activities: 2181808
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2181808 | d7c22ecf-777e-4745-ac8f-bd0cedf6fb26 | Q3 | JEFFREY J. KIMBELL & ASSOCIATES, INC. | 46038 | SANTHERA PHARMACEUTICALS (USA), INC. | 2018 | third_quarter | MED | Issues related to development of treatments for rare diseases. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2018-10-10T12:04:21.500000-04:00 |